Arteris, Inc., together with its subsidiaries, provides semiconductor system intellectual property (IP) solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East.
Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price20.87 USD
Fair value20.52
Ethical score70.0/100
Our investment reviews on this name
2026-08-21Read Distribution28.18-25.9% to today ✓
2026-07-02Read Markup41.00-49.1% to today
Our analytic regime reads on this name, dated and marked against today's price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Arteris, Inc. holds its Markdown at $20.87. Consolidating, no directional conviction, held for 159 days.
As held on the ledger · 2026-09-16
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 159 days
Price at the screen
$20.87
Valuation
N/A trailing · 169.22 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.91
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
5.19%
Below 33%
Interest-bearing debt is just 5.2% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
17.99%
Below 33%
Cash held in interest-bearing accounts and securities is 18.0% of assets, under the one-third limit.
Pass
Receivables
44.68%
Below 49%
Money owed to the company is 44.7% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-16 screen. The gold marker is the market price at the same screen. The price runs 1.7% above the base estimate.
Third-party analyst targets: 6 covering, consensus Strong Buy. The average target sits +92% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-16 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Chip connection tech priced for perfection it lacks
Picture a maze of wires inside every new car or phone chip, where data needs smooth traffic control to avoid jams. Arteris supplies that semiconductor IP, delivering 39% revenue growth in a fast-moving space. Yet the shares sit at $31 against a fair value near $20, with a forward multiple above 197 times earnings and margins still deep in the red at minus 45%. This is not a bargain in a cyclical sector.
The market loves the story and five analysts call it a strong buy with targets near $38. We pass because peak-cycle growth often flatters multiples while losses persist. Low margins and unknown moat in a boom-bust industry turn what looks like expansion into a classic value trap once demand normalises.
Currency swings, customer concentration and sudden chip downturns sit alongside the ethical pass. The numbers show a business still burning cash at current prices. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
AIP trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 9.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 122% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 305%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (4 analysts) rates it none, with a mean price target of $38.
2026-07-21Markup$31.04-24.3%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 24.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 122% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 305%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (4 analysts) rates it none, with a mean price target of $38.
2026-07-18Markup$41.00+0.0%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 122% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 305%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (4 analysts) rates it none, with a mean price target of $38.
2026-07-17Markup$41.00+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 122% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 305%. Our forward projection puts the odds of a 10% gain over the next month near 44%. The street (4 analysts) rates it none, with a mean price target of $38.
2026-07-03Markup$41.00+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$41.00Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
